中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Spevigo (spesolimab-sbzo)
    Spevigo (spesolimab-sbzo)
    departments：皮肤科
    drug：注射剂
    Active：spesolimab-sbzo
    indication：SPEVIGO是一种白细胞介素36受体拮抗剂，用于治疗成人全身性脓疱性银屑病发作。
    Licensor：Boehringer Ingelheim Pharmaceuticals, Inc.
    Approved Country/Region：FDA
    Approval time：2022-09-01